Kuraray (3405) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
8 Aug, 2025Executive summary
First half FY2025 saw net sales decrease 2.7% to ¥399.96B, operating income down 42.2% to ¥26.26B, and net income attributable to owners down 53.9% to ¥14.04B, mainly due to negative inventory valuation and weaker demand, especially in Europe and the US.
Comprehensive income turned negative at -¥17.65B, mainly due to foreign currency translation losses.
Strategic portfolio actions included expansion in optical-use poval film, acquisition of Nelumbo Inc., and withdrawal from underperforming businesses.
Financial highlights
Net sales for FY2025 1H were ¥400.0B, down ¥11.3B year-over-year; operating income fell to ¥26.3B, down ¥19.2B.
Net income attributable to owners was ¥14.0B, a decrease of ¥16.4B compared to the same period last year.
Operating cash flow dropped to ¥42.2B from ¥63.7B; free cash flow turned negative at ¥-7.0B.
CAPEX increased to ¥45.3B, up ¥10.4B year-over-year.
EPS for the interim period was ¥43.50, down from ¥91.20 year-over-year.
Outlook and guidance
Full-year FY2025 net sales forecast revised to ¥840.0B (+1.6% YoY); operating income forecast at ¥75.0B (-11.8%).
Net income forecast for FY2025 is ¥33.0B, up ¥1.3B year-over-year.
Dividend forecast maintained at ¥54 per share; share buyback up to ¥30.0B (22M shares) in progress.
Forecasts based on exchange rates of ¥149/USD and ¥166/EUR, with caution due to global uncertainties.
Latest events from Kuraray
- FY2025 profit dropped on impairments, but FY2026 forecasts a strong rebound and higher dividends.3405
Q4 202610 Feb 2026 - SentryGlas® dominates structural glass with high performance and sustainability, driving global growth.3405
Investor Update19 Dec 2025 - Profits fell over 50% year-over-year; forecasts cut and major share buyback completed.3405
Q3 202612 Nov 2025 - High-performance PVOH products and cell culture solutions drive robust global growth outlook.3405
Investor Day 202519 Jun 2025 - Profits and shareholder returns rose, with robust guidance despite lower sales forecast.3405
Q3 202513 Jun 2025 - Record interim results and upgraded outlook, with increased dividends and share buybacks.3405
Q2 202513 Jun 2025 - Sales up, profits down; full-year outlook steady, major share buyback planned.3405
Q1 20266 Jun 2025 - Record sales and operating income, but net income fell on extraordinary losses; profit recovery forecast.3405
Q4 20255 Jun 2025